Phenylephrine Infusion in Cesarean Delivery

• Status: Unknown status
• Trial end date: 2020-05-25
• Target enrollment: 0
• Participant gender: Female

Summary

the investigators will compare variable infusion of phenylephrine (at a starting rate of 0.75 mcg/Kg/min) with fixed rate (0.75 mcg/Kg/min which will stop of reactive hypertension occurred) and single shot (1.5 mcg/Kg) phenylephrine

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Bupivacaine; Oxymetazoline; Phenylephrine

Criteria

Inclusion Criteria:

• Full term

• Pregnant women

• Scheduled for cesarean delivery

Exclusion Criteria:

• Pre-eclampsia

• Eclampsia

• Hemorrhage

• Cardiac dysfunction

• Baseline low heart rate (below 60 bpm)